Numerous generics manufacturers are now allowed to sell their imitator preparations of the cholesterol-lowering drug Inegy in Germany. The Düsseldorf Regional Court overturned a preliminary injunction (Case No. 4b O37/18 to 4b O43/18) by which it had banned the sale of generics in the spring. The American originator Merck Sharp Dome (MSD) had sued the manufacturers for injunction. The court initially granted the application, but has now lifted the ban.
Representatives 1 A Pharma (4b O37/18) and Hexal (4b O43/18):
Taylor Wessing (Munich): Dr Jan Rektorschek, Dr Nora Wessendorf
Maiwald (Munich): Dr Derk Vos (patent attorney)
The complete Juve article can be downloaded under:
https://www.juve.de/nachrichten/verfahren/2018/10/nachgeprueft-gericht-revidiert-eigenen-beschluss-auf-kosten-von-hogan-lovells-mandantin
